2006Guoji yiyao weisheng daobaoRequires access

Clinical analysis of 41 cases with apiastic anemia

WU Jinquan

Open publisher page 0 citations

Abstract

Objective To analyze the clinical characteristics and diagnosis and treat- ment outcome in 41 cases with aplastic anemia (AA).Method We registered patients newly diagnosed AA between 1993 and 2003 using questionnaires. Retospective analysis was used. Result Of the 41 cases, Treatment effective rate was 80% of chronic AA, 42.9% of severe AA. In chronic AA, the rate was 83.3% in treatment with cyclosporine A combined androgen and 76.9% with androgen alone. In severe AA, the rate was 50% with cyclosporine A combined androgen versus 25% with androgen alone. The main cause of death was brain bleeding (60%).Conclusion Androgen was a main drug for chronic AA. Androgen combined with cyclosporine A could increase the effective rate.But for severe AA, androgen was not an effective drug. Cyclosporine A or ATG was recommended for severe AA. Cyclosporine A combined with ATG and high does methylprednisolone and hematopoietic cytokine would improve the trearment outcome.

About this research paper

What this paper is about

Objective To analyze the clinical characteristics and diagnosis and treat- ment outcome in 41 cases with aplastic anemia (AA).Method We registered patients newly diagnosed AA between 1993 and 2003 using questionnaires. Retospective analysis was used. Result Of the 41 cases, Treatment effective rate was 80% of chronic AA, 42.9% of severe AA. In chronic AA, the rate was 83.3% in treatment with cyclosporine A combined androgen and 76.9% with androgen alone. In severe AA, the rate was 50% with cyclosporine A combined androgen versus 25% with androgen alone. The main cause of death was brain bleeding (60%).Conclusion Androgen was a main drug for chronic AA. Androgen combined with cyclosporine A could increase the effective rate.But for severe AA, androgen was not an effective drug. Cyclosporine A or ATG was recommended for severe AA. Cyclosporine A combined with ATG and high does methylprednisolone and hematopoietic cytokine would improve the trearment outcome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To analyze the clinical characteristics and diagnosis and treat- ment outcome in 41 cases with aplastic anemia (AA).Method We registered patients newly diagnosed AA between 1993 and 2003 using questionnaires. Retospective analysis was used. Result Of the 41 cases, Treatment effective rate was 80% of chronic AA, 42.9% of severe AA. In chronic AA, the rate was 83.3% in treatment with cyclosporine A combined androgen and 76.9% with androgen alone. In severe AA, the rate was 50% with cyclosporine A combined androgen versus 25% with androgen alone. The main cause of death was brain bleeding (60%).Conclusion Androgen was a main drug for chronic AA. Androgen combined with cyclosporine A could increase the effective rate.But for severe AA, androgen was not an effective drug. Cyclosporine A or ATG was recommended for severe AA. Cyclosporine A combined with ATG and high does methylprednisolone and hematopoietic cytokine would improve the trearment outcome.

Key concepts: Medicine, Androgen, Gastroenterology, Methylprednisolone, Aplastic anemia, Anemia, Internal medicine, Drug

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical analysis of 41 cases with apiastic anemia — Research Paper | ScholarLens